Punch & Associates Investment Management Inc. Has $4.58 Million Stock Holdings in UFP Technologies, Inc. $UFPT

Key Points

• Punch & Associates Investment Management Inc. has decreased its stake in UFP Technologies, Inc. by 39.0%, owning 22,700 shares after selling 14,500 shares in the first quarter.
• Wall Street analysts have a positive outlook, with Lake Street Capital raising its price target for UFP Technologies from $252.00 to $289.00 and giving it a "buy" rating.
• UFP Technologies reported quarterly earnings of $2.50 per share, exceeding estimates, and achieved revenue of $151.18 million, a 37.2% increase year-over-year.

Punch & Associates Investment Management Inc. trimmed its position in shares of UFP Technologies, Inc. (NASDAQ:UFPT - Free Report) by 39.0% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 22,700 shares of the industrial products company's stock after selling 14,500 shares during the period. Punch & Associates Investment Management Inc. owned about 0.29% of UFP Technologies worth $4,579,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds also recently bought and sold shares of UFPT. Lazard Asset Management LLC bought a new stake in UFP Technologies in the fourth quarter worth approximately $84,000. State of Wyoming lifted its position in shares of UFP Technologies by 34.7% in the first quarter. State of Wyoming now owns 365 shares of the industrial products company's stock worth $74,000 after buying an additional 94 shares during the last quarter. Park Square Financial Group LLC bought a new stake in shares of UFP Technologies during the 4th quarter worth about $107,000. CreativeOne Wealth LLC acquired a new position in shares of UFP Technologies during the 1st quarter valued at about $203,000. Finally, Dakota Wealth Management bought a new position in shares of UFP Technologies in the 1st quarter valued at approximately $204,000. 87.28% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Separately, Lake Street Capital upped their target price on UFP Technologies from $252.00 to $289.00 and gave the stock a "buy" rating in a research report on Wednesday, August 6th. One research analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat, UFP Technologies currently has an average rating of "Moderate Buy" and a consensus price target of $289.00.

UFP Technologies Stock Performance

Shares of UFPT stock traded up $0.16 during trading hours on Thursday, reaching $201.37. 116,276 shares of the company's stock were exchanged, compared to its average volume of 133,176. UFP Technologies, Inc. has a fifty-two week low of $178.26 and a fifty-two week high of $366.41. The company has a quick ratio of 1.53, a current ratio of 2.77 and a debt-to-equity ratio of 0.39. The stock has a market capitalization of $1.55 billion, a P/E ratio of 23.33 and a beta of 1.20. The business has a fifty day moving average price of $225.48 and a 200-day moving average price of $223.71.

UFP Technologies (NASDAQ:UFPT - Get Free Report) last announced its quarterly earnings data on Monday, August 4th. The industrial products company reported $2.50 EPS for the quarter, topping analysts' consensus estimates of $2.25 by $0.25. UFP Technologies had a return on equity of 21.54% and a net margin of 11.40%.The company had revenue of $151.18 million during the quarter, compared to the consensus estimate of $151.55 million. During the same quarter last year, the company earned $1.86 EPS. The company's quarterly revenue was up 37.2% on a year-over-year basis.

UFP Technologies Profile

UFP Technologies, Inc designs and manufactures solutions for medical devices, sterile packaging, and other highly engineered custom products. The company offers protective drapes for robotic surgery, single patient use surfaces, advanced wound care, infection prevention, disposables for surgical and endoscopic procedures, packaging for medical devices, orthopedic implants, biopharma drug manufacturing, and coils for catheters; and molded components for applications in acoustic insulation, interior trim, load floors, sunshades, SUV cargo cover handles, driveshaft damping, engine and manifold covers, quarter panels, and wheel liners.